HRAS and Hyperkeratosis: Several reports have demonstrated that MEK inhibitors improve HRAS-driven tumorigenesis46, impaired enamel formation in the teeth27, and long-term depression in the hippocampus in Hras G12V knock-in mice28, as well as hyperkeratosis and hyperplasia in the forestomach of BrafQ241R/+ mice26.